L3MBTL3 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)

Catalog No. ABIN2724448

This Recombinant L3MBTL3 protein is expressed in HEK-293 Cells.

Quick Overview for L3MBTL3 Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag) (ABIN2724448)

Target: L3MBTL3 (L(3)mbt-Like 3 (L3MBTL3))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Protein Characteristics: Transcript Variant 2

Purification tag / Conjugate: This L3MBTL3 protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human L3MBTL3 (transcript variant 2) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: L3MBTL3 (L(3)mbt-Like 3 (L3MBTL3))

Alternative Name: l3mbtl3

Background: This gene encodes a member of the malignant brain tumor (MBT) family of chromatin interacting transcriptional repressors. Members of this family function as methyl-lysine readers, which recognize methylated lysine residues on histone protein tails, and are associated with the repression of gene expression. The encoded protein may regulate hematopoiesis. Homozygous deletion of this gene has been observed in human patients with medulloblastoma.

Molecular Weight: 85.6 kDa

NCBI Accession: NP_001007103